BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, April 20, 2026
Home » Blogs » BioWorld MedTech Perspectives » Top Five ways to tell if you're a med-tech geek

BioWorld MedTech Perspectives
BioWorld MedTech Perspectives RSS FeedRSS

Medical technology

Top Five ways to tell if you're a med-tech geek

July 15, 2011
By Mark McCarty

Can't stop staring at me? You're a med-tech geek!

We all find ourselves immersed in our work at times, but some jobs have tremendously broad appeal while others don't. For instance, lots of people want to own a vineyard, but even people who don't care for the idea like to talk about wine.

In comparison, there are people like me whose heads are full of things most people don't care about. One day a few months back, I sauntered about mulling over the med-tech policy ramifications of something or other. Some time later, I noticed a police officer following me in his cruiser as I wandered.

I started explaining this predicament to him and it dawned on me that he wasn't interested. Not even a little bit. I came out of it and said to myself “Oh, for Pete's sake, would you listen to yourself? He doesn't care!”

Then he pointed to the cars and trucks hurtling past at dozens of miles per hour (which they don't often do on Interstate 66 in this part of Virginia).

That's when it dawned on me: I'm a med-tech geek.

Since that day, I've learned to accept my condition. No, there are no 12-step groups for this, but I'll be okay thanks to something Master What's-his-name said about finding one's purpose in life. He said, “follow your inner geek, Grasshopper,” or something like that.

Do you ever wonder if you're a med-tech geek? Here's how to figure out if you are. I should warn you, though: If only one applies to you, you're already in grave danger.

If all five apply to you? Oy.

Five: You look forward to conferences like Transcatheter Cardiovascular Therapeutics because there's always an FDA town hall discussion of device-specific guidances, some of which run disturbingly close to 100 pages.

Four: You can finally pronounce “February” correctly because you had to learn to say “defibrillator” without sounding like an idiot. However, this has not helped with your “nukular” problem in the least.

Three: You think the object in this picture is fascinating, even if you haven't the foggiest idea what it is or what it's used for.

Two: You start telling someone you meet at Starbucks about a new Medicare coverage analysis and you keep going even after his eyes glaze over and his jaw goes slack. You keep at it until his eyes roll back in his head and he starts drooling like a St. Bernard.

When the ambulance arrives, you defiantly bellow “defibrillator!” from a safe distance.

One: You're the last one on your street to find out that some people use transcutaneous electrical nerve stimulators in foreplay.

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 17, 2026.
  • Man holding raised arm with illustrated overlay of nerves

    Biohaven reports details on discovery of BHV-2100

    BioWorld Science
    Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
  • New GABA(B) receptor PAMs revealed in Addex Pharma patents

    BioWorld Science
    Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
  • Elderly woman holding illustration of brain with missing puzzle piece

    Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’

    BioWorld
    The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
  • Novel caspase-2 inhibitor shows in vivo neuroprotective effects

    BioWorld Science
    Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing